» Articles » PMID: 32351766

Management of Hyperactive Delirium in the Pediatric Intensive Care Unit: Case Series of Three Young Children

Overview
Date 2020 May 1
PMID 32351766
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Children in the intensive care unit (ICU) are at high risk of developing delirium, given their underlying disease processes, the adverse effects of treatments and medications, and the stressful, abnormal environment. If prevention and nonpharmacologic measures to treat delirium are unsuccessful, atypical antipsychotics are considered, although they are not approved by Food and Drug Administration for the treatment of pediatric delirium and could have significant adverse side effects. This case report presents three pediatric patients with hyperactive ICU delirium that risked life-threating complications who were successfully treated with short courses of atypical antipsychotic medications.

Citing Articles

Current Evidence Regarding the Evaluation and Management of Neonatal Delirium.

Ruth O, Tomajko S, Dabaja E, Munsel E, Rice K, Cwynar C Curr Psychiatry Rep. 2024; 26(12):744-752.

PMID: 39446295 DOI: 10.1007/s11920-024-01550-z.


Challenges in management of refractory pain and sedation in infants.

Oschman A, Rao K Front Pharmacol. 2024; 14:1259064.

PMID: 38235119 PMC: 10791862. DOI: 10.3389/fphar.2023.1259064.


Avoiding a Poke: A Case Series of Intravenous Olanzapine in Pediatric Patients.

Hassan A, Raschka M J Pediatr Pharmacol Ther. 2023; 28(8):752-756.

PMID: 38094671 PMC: 10715377. DOI: 10.5863/1551-6776-28.8.752.


Implementation and effectiveness of a delirium care protocol in Thai critically ill children.

Chaiyakulsil C, Thadahirunchot T Acute Crit Care. 2023; 38(4):488-497.

PMID: 38052514 PMC: 10718492. DOI: 10.4266/acc.2023.00045.


High-Dose Dexmedetomidine for Severe Hyperactive Delirium Secondary to Intravenous Levetiracetam on Two Separate Occasions in the Same Patient.

Ward C, Khalid K, Rozette N Case Rep Psychiatry. 2022; 2022:1843774.

PMID: 35818414 PMC: 9271000. DOI: 10.1155/2022/1843774.

References
1.
Turkel S . Pediatric Delirium: Recognition, Management, and Outcome. Curr Psychiatry Rep. 2017; 19(12):101. DOI: 10.1007/s11920-017-0851-1. View

2.
Hui T, Wong A, Wijesinghe R . A review on mortality risks associated with antipsychotic use in behavioral and psychologic symptoms of dementia (BPSD). Ment Health Clin. 2018; 6(5):215-221. PMC: 6007591. DOI: 10.9740/mhc.2016.09.215. View

3.
Ratcliff S, Meyer 3rd W, Cuervo L, Villarreal C, Thomas C, Herndon D . The use of haloperidol and associated complications in the agitated, acutely ill pediatric burn patient. J Burn Care Rehabil. 2004; 25(6):472-8. DOI: 10.1097/01.bcr.0000144540.21272.2c. View

4.
Traube C, Silver G, Reeder R, Doyle H, Hegel E, Wolfe H . Delirium in Critically Ill Children: An International Point Prevalence Study. Crit Care Med. 2017; 45(4):584-590. PMC: 5350030. DOI: 10.1097/CCM.0000000000002250. View

5.
Silver G, Kearney J, Traube C, Hertzig M . Delirium screening anchored in child development: The Cornell Assessment for Pediatric Delirium. Palliat Support Care. 2014; 13(4):1005-11. PMC: 5031084. DOI: 10.1017/S1478951514000947. View